Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of SCE-B on Nocturnal Vasomotor Symptoms in Postmenopausal Women

NCT00592839 is registered in ClinicalTrials.gov with Duramed Research as lead sponsor.

NCT NCT00592839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00592839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of SCE-B on Nocturnal Vasomotor Symptoms in Postmenopausal Women
Lead sponsor
Duramed Research
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2007
Completion date
February 28, 2009
Enrollment
157 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

nocturnal vasomotor symptoms